Thomas B. Okarma

Thomas B. Okarma

Directeur Technique/Scientifique/R&D chez Rejuvenan Global Health, Inc.

78 ans
Health Technology
Consumer Services
Commercial Services

Profil

Thomas B.
Okarma
was the founder of Applied Immune Sciences, Inc. founded in 1985, where he held the title of Chairman & Chief Executive Officer in 1995.
Currently, he is a Director at Biotechnology Innovation Organization, Rejuvenan Global Health, Inc., and Geron Bio-Med Ltd.
In the past, he served as President, Chief Executive Officer & Director at Geron Corp.
from 1998 to 2011, and as President, Chief Executive Officer & Director at Asterias Biotherapeutics, Inc. from 2012 to 2014.
He also held the position of Senior Vice President at Rhone-Poulenc Rorer, Inc. in 1995 and Vice President at Cell Therapies Pty Ltd.
in 1997-1998.
Dr. Okarma received his undergraduate degree from Dartmouth College and his doctorate from Stanford University.

Postes actifs de Thomas B. Okarma

SociétésPosteDébut
Geron Bio-Med Ltd. Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur Technique/Scientifique/R&D -
Tous les postes actifs de Thomas B. Okarma

Anciens postes connus de Thomas B. Okarma

SociétésPosteFin
ASTERIAS BIOTHERAPEUTICS INC Directeur Général 10/04/2014
GERON CORPORATION President 08/02/2011
Cell Therapies Pty Ltd. Corporate Officer/Principal 01/05/1998
Corporate Officer/Principal 01/12/1996
Fondateur 01/01/1995
Voir l'expérience en détail de Thomas B. Okarma

Formation de Thomas B. Okarma

Dartmouth College Undergraduate Degree
Stanford University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas B. Okarma

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
GERON CORPORATION

Health Technology

Entreprise privées7

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Geron Bio-Med Ltd.

Cell Therapies Pty Ltd.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas B. Okarma